MIHAELA STEFANIA STEFAN

Dr. MIHAELA STEFANIA STEFAN


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
KRKarthik Raghunathan
Karthik Raghunathan
ASAndrew Shaw
Andrew Shaw
BNBrian Nathanson
Brian Nathanson
TSTil Stürmer
Til Stürmer
ABAlan Brookhart
Alan Brookhart
PLPeter K. Lindenauer
Peter K. Lindenauer
Isotonic saline is the most commonly used crystalloid in the ICU, but recent evidence suggests that balanced fluids like Lactated Ringer’s solution may be preferable. We examined the association between choice of crystalloids and in-hospital mortality during the resuscitation of critically ill adults with sepsis. A retrospective cohort study of patients admitted with sepsis, not undergoing any surgical procedures, and treated in an ICU by hospital day 2. We used propensity score matching to control for confounding and compared the following outcomes after resuscitation with balanced versus with no-balanced fluids: in-hospital mortality, acute renal failure with and without dialysis, and hospital and ICU lengths of stay. We also estimated the dose-response relationship between receipt of increasing proportions of balanced fluids and in-hospital mortality. Three hundred sixty U.S. hospitals that were members of the Premier Healthcare alliance between November 2005 and December 2010. A total of 53,448 patients with sepsis, treated with vasopressors and crystalloids in an ICU by hospital day 2 including 3,396 (6.4%) that received balanced fluids. None. Patients treated with balanced fluids were younger and less likely to have heart or chronic renal failure, but they were more likely to receive mechanical ventilation, invasive monitoring, colloids, steroids, and larger crystalloid volumes (median 7 vs 5 L). Among 6,730 patients in a propensity-matched cohort, receipt of balanced fluids was associated with lower in-hospital mortality (19.6% vs 22.8%; relative risk, 0.86; 95% CI, 0.78, 0.94). Mortality was progressively lower among patients receiving larger proportions of balanced fluids. There were no significant differences in the prevalence of acute renal failure (with and without dialysis) or in-hospital and ICU lengths of stay. Among critically ill adults with sepsis, resuscitation with balanced fluids was associated with a lower risk of in-hospital mortality. If confirmed in randomized trials, this finding could have significant public health implications, as crystalloid resuscitation is nearly universal in sepsis.

1 December 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
PLPeter K. Lindenauer
Peter K. Lindenauer
MSMIHAELA STEFANIA STEFAN
MIHAELA STEFANIA STEFAN
MSMeng-Shiou Shieh
Meng-Shiou Shieh
PPPenelope S. Pekow
Penelope S. Pekow
MRMichael B. Rothberg
Michael B. Rothberg
NHNicholas S. Hill
Nicholas S. Hill
Chronic obstructive pulmonary disease (COPD) affects 4% to 7% of US adults, results in more than 800 000 hospitalizations annually, and is the nation’s third leading cause of death.1-3 Treatment for patients hospitalized with exacerbation include supplemental oxygen, short-acting bronchodilators, systemic corticosteroids, and, in most instances, antibiotics.4-6 Meta-analyses of randomized clinical trials suggest that when administered to carefully selected patients, noninvasive ventilation (NIV) can reduce the risk of death by up to 55%,5,7 the only hospital-based intervention known to improve mortality. This benefit is thought to be mediated through the prevention of complications associated with invasive mechanical ventilation (IMV), including ventilator-associated pneumonia and barotrauma.8-10

18 January 2013 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
MSMIHAELA STEFANIA STEFAN
MIHAELA STEFANIA STEFAN
MSMeng‐Shiou Shieh
Meng‐Shiou Shieh
PPPenelope S. Pekow
Penelope S. Pekow
MRMichael B. Rothberg
Michael B. Rothberg
JSJay S. Steingrub
Jay S. Steingrub
PLPeter K. Lindenauer
Peter K. Lindenauer

31 August 2012 in Thorax
Verified
Journal Article
Open access
PDF file
MSMIHAELA STEFANIA STEFAN
MIHAELA STEFANIA STEFAN
MRMichael B Rothberg
Michael B Rothberg
APAruna Priya
Aruna Priya
PPPenelope S Pekow
Penelope S Pekow
DADavid H Au
David H Au
PLPeter K Lindenauer
Peter K Lindenauer
Background β-Blocker therapy has been shown to improve survival among patients with ischaemic heart disease (IHD) and congestive heart failure (CHF) and is underused among patients with chronic obstructive pulmonary disease (COPD). Evidence regarding the optimal use of β-blocker therapy during an acute exacerbation of COPD is particularly weak. Methods We conducted a retrospective cohort study of patients aged ≥40 years with IHD, CHF or hypertension who were hospitalised for an acute exacerbation of COPD from 1 January 2006 to 1 December 2007 at 404 acute care hospitals throughout the USA. We examined the association between β-blocker therapy and in-hospital mortality, initiation of mechanical ventilation after day 2 of hospitalisation, 30-day all-cause readmission and length of stay. Results Of 35 082 patients who met the inclusion criteria, 29% were treated with β blockers in the first two hospital days, including 22% with β1-selective and 7% with non-selective β blockers. In a propensity-matched analysis, there was no association between β-blocker therapy and in-hospital mortality (OR 0.88, 95% CI 0.71 to 1.09), 30-day readmission (OR 0.96, 95% CI 0.89 to 1.03) or late mechanical ventilation (OR 0.98, 95% CI 0.77 to 1.24). However, when compared with β1 selective β blockers, receipt of non-selective β blockers was associated with an increased risk of 30-day readmission (OR 1.25, 95% CI 1.08 to 1.44). Conclusions Among patients with IHD, CHF or hypertension, continuing β1-selective β blockers during hospitalisation for COPD appears to be safe. Until additional evidence becomes available, β1-selective β blockers may be superior to treatment with a non-selective β blocker.

16 October 2012 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
MSMIHAELA STEFANIA STEFAN
MIHAELA STEFANIA STEFAN
PPPenelope S. Pekow
Penelope S. Pekow
WNWato Nsa
Wato Nsa
APAruna Priya
Aruna Priya
LMLauren E. Miller
Lauren E. Miller
PLPeter K. Lindenauer
Peter K. Lindenauer

1 July 2015 in Critical Care Medicine
Verified
Journal Article
Closed access
MSMIHAELA STEFANIA STEFAN
MIHAELA STEFANIA STEFAN
BNBrian H. PhD Nathanson
Brian H. PhD Nathanson
THThomas L. Md Higgins
Thomas L. Md Higgins
JSJay S. Steingrub
Jay S. Steingrub
TLTara Lagu
Tara Lagu
PLPeter K. Md Lindenauer
Peter K. Md Lindenauer
Objectives: To compare the characteristics and hospital outcomes of patients with an acute exacerbation of chronic obstructive pulmonary disease treated in the ICU with initial noninvasive ventilation or invasive mechanical ventilation. Design: Retrospective, multicenter cohort study of prospectively collected data. We used propensity matching to compare the outcomes of patients treated with noninvasive ventilation to those treated with invasive mechanical ventilation. We also assessed predictors for noninvasive ventilation failure. Setting: Thirty-eight hospitals participating in the Acute Physiology and Chronic Health Evaluation database from 2008 through 2012. Subjects: A total of 3,520 patients with a diagnosis of chronic obstructive pulmonary disease exacerbation including 27.7% who received noninvasive ventilation and 45.5% who received invasive mechanical ventilation. Interventions: None. Measurements and Main Results: Noninvasive ventilation failure was recorded in 13.7% from patients ventilated noninvasively. Hospital mortality was 7.4% for patients treated with noninvasive ventilation; 16.1% for those treated with invasive mechanical ventilation; and 22.5% for those who failed noninvasive ventilation. In the propensity-matched analysis, patients initially treated with noninvasive ventilation had a 41% lower risk of death compared with those treated with invasive mechanical ventilation (relative risk, 0.59; 95% CI, 0.36–0.97). Factors that were independently associated with noninvasive ventilation failure were Simplified Acute Physiology Score II (relative risk = 1.04 per point increase; 95% CI, 1.03–1.04) and the presence of cancer (2.29; 95% CI, 0.96–5.45). Conclusions: Among critically ill adults with chronic obstructive pulmonary disease exacerbation, the receipt of noninvasive ventilation was associated with a lower risk of in-hospital mortality compared with that of invasive mechanical ventilation; noninvasive ventilation failure was associated with the worst outcomes. These results support the use of noninvasive ventilation as a first-line therapy in appropriately selected critically ill patients with chronic obstructive pulmonary disease while also highlighting the risks associated with noninvasive ventilation failure and the need to be cautious in the face of severe disease.